AzTrials
AzTrials

General AnesthesiaBis-qCon-HalNCT03359512

Comparison of Two Electroencephalograms (EEG) Monitors in Patients Undergoing General Anesthesia With Sevoflurane

A study testing qCON monitor in people with General Anesthesia, run by Hopital Foch at 1 site in France.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

Quantium Medical Company has an ElectoEcenphalograph-based (EEG-based) algorithm with two outputs: qCON for unconsciousness and qNOX for anti-nociception. qCON, is designed to provide information about the depth of the hypnotic state, similar to that provided by the BIS™. Read more about this study

Who is it for?
Ages 18 years and older
Conditions the study is for
General Anesthesia
What is being tested?
qCON monitor
Type of treatment
Medical device
Could I receive a placebo?
No, everyone receives an active treatment
How many people
46 participants
Where
1 siteFrance
Study dates
21 Nov 2017to 16 Mar 2018
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • Patients affiliated to a national insurance scheme or benefiting from such a program
  • Patients having given their written consent.
  • Patients that must benefit from a general anesthesia with the aim of a surgical act of a duration of at least one hour
  • Patients that must benefit from a general anesthesia including a maintenance by the sevoflurane.
  • For the patients taken care in ambulatory surgery, having a telephone and agreeing to communicate their phone number

Who cannot join

  • Pregnant or breast-feeding Women
  • Patients having a limit of use of the Bispectral Index (BIS) or qCON monitor ,
  • Patients having a contraindication in the propofol.
  • Patients taken care in ambulatory surgery who could not be contacted within 24 hours following the surgical operation;

Trial locations and contacts

1 site in 1 country.

France1 site
  • Hopital Foch

    Suresnes, 92150

Other trials in France

About this study

Quantium Medical Company has an ElectoEcenphalograph-based (EEG-based) algorithm with two outputs: qCON for unconsciousness and qNOX for anti-nociception. qCON, is designed to provide information about the depth of the hypnotic state, similar to that provided by the BIS™.

Being tested
qCON monitor
Keywords
anesthesia monitoring

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • qCON monitorDevice

    supervision by qCON monitor of the depth of anesthesia

Study groups in NCT03359512
Study groupRoleWhat they receive
qCON monitorExperimentalSimultaneous measurement of BIS and qCON
Receives: Device: qCON monitor

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. qCON monitoring during maintenance of anesthesia

    Measurement of qCON values

    Measured: up to 10 hours

Secondary outcomes (10)
  1. BIS monitoring during maintenance of anesthesia

    Measurement of BIS values each 5 seconds during maintenance of anesthesia

    Measured: One day

  2. qCON monitoring during induction of anesthesia

    Measurement of qCON values each 5 seconds during induction of anesthesia

    Measured: One day

  3. BIS monitoring during induction of anesthesia

    Measurement of BIS values each 5 seconds during induction of anesthesia

    Measured: One day

  4. qCON monitoring during recovery of anesthesia

    Measurement of qCON values each 5 seconds during recovery of anesthesia

    Measured: One day

  5. BIS monitoring during recovery of anesthesia during recovery of anesthesia

    Measurement of BIS values each 5 seconds

    Measured: One day

  6. Burst Suppression ratio retrieved by qCON monitoring

    Measurement of Burst Suppression ratio values each 5 seconds during anesthesia

    Measured: One day

  7. Burst Suppression ratio retrieved by BIS monitoring

    Measurement of Burst Suppression ratio values each 5 seconds during anesthesia

    Measured: One day

  8. qNOX monitoring during anesthesia

    Measurement of qNOX values each 5 seconds during anesthesia

    Measured: One day

  9. Periods of loss of signal of qCON

    Measurement of qCON values each 5 seconds during anesthesia

    Measured: One day

  10. Periods of loss of signal of BIS during anesthesia

    Measurement of BIS values each 5 seconds

    Measured: One day

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted2 Dec 2017
  2. Study start21 Nov 2017
  3. Primary completion16 Mar 2018
  4. Study completion16 Mar 2018

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Other
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrolment
46 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT03359512
Sponsor's protocol ID
2016/30
Other IDs
2016-A01088-43
Acronym
Bis-qCon-Hal
Status last verified
Nov 2017
First submitted
6 Nov 2017
Last updated
24 Aug 2018
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Questions about this trial

What is this clinical trial studying?

A study testing qCON monitor in people with General Anesthesia, run by Hopital Foch at 1 site in France.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 5 inclusion and 4 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 24 Aug 2018. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in France. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

qCON monitoring during maintenance of anesthesia (time frame: up to 10 hours). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 24 Aug 2018; AzTrials last refreshed its copy on 6 Nov 2026.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in